USASpending / award record
FY2025 SBIR CONCEPT CLEARANCE AWARD FOR TOPIC DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS.
Source: USASpending · CONT_AWD_75N91025C00012_7529_-NONE-_-NONE- · As of 2026-09-14 · Last synced 2026-11-10
Dates reflect the source record. Options and extensions exist; an end date does not establish that a contract will be recompeted, renewed, or terminated.
- source record id
- CONT_AWD_75N91025C00012_7529_-NONE-_-NONE-
- generated unique award id
- CONT_AWD_75N91025C00012_7529_-NONE-_-NONE-
- source
- USASpending
- award id piid
- 75N91025C00012
- vendor name as awarded
- TENACI-T THERAPEUTICS LLC
- vendor uei
- MTRTYVL8N717
- agency name
- Department of Health and Human Services
- sub agency
- National Institutes of Health
- contract title or description
- FY2025 SBIR CONCEPT CLEARANCE AWARD FOR TOPIC DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS.
- naics code
- 541715
- naics description
- RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- psc code
- AN11
- texas nigp code
- Not published
- value obligated
- 297621
- Total / ceiling as published (not obligated)
- Not published
- pop start date
- 2025-09-17T05:00:00.000Z
- expiry date
- 2027-09-16T05:00:00.000Z
- place of performance state
- TX
- recipient location state
- TX
- set aside type
- SMALL BUSINESS SET ASIDE - TOTAL
- source as of
- 2026-09-14T05:00:00.000Z
- last synced
- 2026-11-10T06:00:00.000Z
- published
- true
- Source expiry field
- Period of performance current end date (USASpending)